Adjustable intragastric balloon for treatment of obesity: a multicentre, open-label, randomised clinical trial.
Barham KAD, Maselli DB, Rapaka B, Lavin T, Noar M, Hussan H et al.
Lancet 2021; 398: 1965-1973.
This multicentre study included 288 patients randomized to lifestyle intervention with additional intragastric balloon therapy. After 32 weeks, mean total bodyweight loss was greater in the balloon group: 15 versus 3.3 per cent (P,0.0001). Some 17 per cent of balloons were removed for intolerance.
Comment: This is now an old technology that has never really taken off.
1 January 2022Read paper
Part of the charitable activity of the Society, BJS Academy is an online educational resource for current and future surgeons.
The Academy is comprised of five distinct sections: Continuing surgical education, Young BJS, Cutting edge, Scientific surgery and Surgical news. Although the majority of this is open access, additional content is available to BJS subscribers and strategic partners.